Pharmaceuticals Corporate Finance Earnings Reports Pharmaceuticals Stock Market Drug Development Pharmaceuticals Stock Performance Market Analysis Corporate Strategy
The Danish drugmaker expects U.S. Wegovy sales to recover in H2 2025 following FDA enforcement and a new CVS formulary deal, despite lowering growth forecasts due to compounding competition.